May 21, 2014
NOTICE: Board of Registration in Podiatry Approves Emergency Regulations Regarding Hydrocodone-only Extended Release Medication (Zohydro ER)
On May 13, 2014, the Board of Registration in Podiatry approved emergency regulations that place certain restrictions on the ability of licensed podiatrists to prescribe hydrocodone-only extended release medication that is not in an abuse deterrent form (commonly known as Zohydro ER).
The emergency regulations require licensed podiatrists to complete a risk assessment and pain management treatment agreement prior to prescribing any patient hydrocodone-only extended-release medication that is not in abuse-deterrent form. The agreement with each patient must address drug screening, pill counts, safe storage and disposal, and other requirements as appropriate in the prescriber’s judgment. In addition, the emergency regulations also require licensed podiatrists to complete a continuing education course in opiate education.
The emergency regulations amend 249 CMR 3.00 - 4.00 and are effective as of May 19th, for a period of 90 days. During that time, the Board will commence the formal rulemaking process to permanently implement these amendments to its regulations. Copies of the approved, emergency regulations are available through the links below:
- 249 CMR 3.00 (redline version)
- 249 CMR 3.00 (clean version)
- 249 CMR 4.00 (redline version)
- 249 CMR 4.00 (clean version)